Approved Ligands

Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.

Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.

Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.

Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.

Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.

Potent calcineurin inhibitor: immunosuppressant.

Potent calcineurin inhibitor: immunosuppressant.

Potent calcineurin inhibitor: immunosuppressant.

Potent calcineurin inhibitor: immunosuppressant.

Tadalafil is a PDE-5 inhibitor with IC50 of 1.8 nM.Tadalafil是PDE5抑制剂，IC50为1.8 nM。(A phosphodiesterase 5 inhibitor).

Tadalafil is a PDE-5 inhibitor with IC50 of 1.8 nM.Tadalafil是PDE5抑制剂，IC50为1.8 nM。(A phosphodiesterase 5 inhibitor).

Tadalafil is a PDE-5 inhibitor with IC50 of 1.8 nM.Tadalafil是PDE5抑制剂，IC50为1.8 nM。(A phosphodiesterase 5 inhibitor).